title: Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy.
abstract: Image-guided brachytherapy in cervical cancer is increasingly replacing X-ray based dose planning. In image-guided brachytherapy the geometry of the applicator is extracted from the patient 3D images and introduced into the treatment planning system; a process referred to as applicator reconstruction. Due to the steep brachytherapy dose gradients, reconstruction errors can lead to major dose deviations in target and organs at risk. Appropriate applicator commissioning and reconstruction methods must be implemented in order to minimise uncertainties and to avoid accidental errors. Applicator commissioning verifies the location of source positions in relation to the applicator by using auto-radiography and imaging. Sectional imaging can be utilised in the process, with CT imaging being the optimal modality. The results from the commissioning process can be stored as library applicators. The importance of proper commissioning is underlined by the fact that errors in library files result in systematic errors for clinical treatment plans. While the source channel is well visualised in CT images, applicator reconstruction is more challenging when using MR images. Availability of commercial dummy sources for MRI is limited, and image artifacts may occur with titanium applicators. The choice of MR sequence is essential for optimal visualisation of the applicator. Para-transverse imaging (oriented according to the applicator) with small slice thickness (< or =5 mm) is recommended or alternatively 3D MR sequences with isotropic voxel sizes. Preferably, contouring and reconstruction should be performed in the same image series in order to avoid fusion uncertainties. Clear and correct strategies for the applicator reconstruction will ensure that reconstruction uncertainties have limited impact on the delivered dose. Under well-controlled circumstances the reconstruction uncertainties are in general smaller than other brachytherapy uncertainties such as contouring and organ movement.
authors.affiliation: Department of Medical Physics, Division of Cancer and Surgery, Oslo University Hospital, Norway. Taran.Paulsen.Hellebust@nrpa.no
authors.forename: Taran Paulsen
authors.initials: TP
authors.lastname: Hellebust
authors.forename: Christian
authors.initials: C
authors.lastname: Kirisits
authors.forename: Daniel
authors.initials: D
authors.lastname: Berger
authors.forename: José
authors.initials: J
authors.lastname: Pérez-Calatayud
authors.forename: Marisol
authors.initials: M
authors.lastname: De Brabandere
authors.forename: Astrid
authors.initials: A
authors.lastname: De Leeuw
authors.forename: Isabelle
authors.initials: I
authors.lastname: Dumas
authors.forename: Robert
authors.initials: R
authors.lastname: Hudej
authors.forename: Gerry
authors.initials: G
authors.lastname: Lowe
authors.forename: Rachel
authors.initials: R
authors.lastname: Wills
authors.forename: Kari
authors.initials: K
authors.lastname: Tanderup
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D005260:Female; D006287:Health Planning Guidelines; D006801:Humans; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D010347:Patient Care Planning; D011859:Radiography; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*